Contrast induced encephalopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
Retention of contrast in the brain is rare, and has been documented in only a handful of cases <ref name="pmid8793235">{{cite journal | author = Muruve DA, Steinman TI | title = Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency | journal = [[Clinical Nephrology]] | volume = 45 | issue = 6 | pages = 406–9 | year = 1996 | month = June | pmid = 8793235 | doi = | url = | issn = | accessdate = 2011-02-05}}</ref>. Contrast induced encephalopathy is also a rare disorder in which an [[encephalopathy]] occurs following iodinated contrast injections. It has been observed following angioplasty <ref name="pmid17943057">{{cite journal | author = Sawaya RA, Hammoud R, Arnaout S, Alam S | title = Contrast-induced encephalopathy following coronary angioplasty with iohexol | journal = [[Southern Medical Journal]] | volume = 100 | issue = 10 | pages = 1054–5 | year = 2007 | month = October | pmid = 17943057 | doi = 10.1097/SMJ.0b013e3181540086 | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0038-4348&volume=100&issue=10&spage=1054 | issn = | accessdate = 2011-02-05}}</ref><ref name="pmid8793235">{{cite journal | author = Muruve DA, Steinman TI | title = Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency | journal = [[Clinical Nephrology]] | volume = 45 | issue = 6 | pages = 406–9 | year = 1996 | month = June | pmid = 8793235 | doi = | url = | issn = | accessdate = 2011-02-05}}</ref>. It is associated with diffuse slowing on the [[EEG]]. The disorder is usually self limited and resolves within 24 hours. Patients with impaired creatinine clearance may be at increased risk for the disorder. Treatment is largely supportive, although one small study of 3 patients reports that [[craniectomy]] was successfully used to reduce cerebral edema <ref>A proposed treatment modality for contrast-induced encephalopathy C. Pineda, D. Brock, R. Bell, J. Provencio, L. Tartaglin. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 1 September 2003 (volume 12 issue 5 Page 249 DOI: 10.1016/j.jstrokecerebrovasdis.2003.11.012)</ref>. | Retention of contrast in the brain is rare, and has been documented in only a handful of cases <ref name="pmid8793235">{{cite journal | author = Muruve DA, Steinman TI | title = Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency | journal = [[Clinical Nephrology]] | volume = 45 | issue = 6 | pages = 406–9 | year = 1996 | month = June | pmid = 8793235 | doi = | url = | issn = | accessdate = 2011-02-05}}</ref>. Contrast induced encephalopathy is also a rare disorder in which an [[encephalopathy]] occurs following iodinated contrast injections. It has been observed following angioplasty <ref name="pmid17943057">{{cite journal | author = Sawaya RA, Hammoud R, Arnaout S, Alam S | title = Contrast-induced encephalopathy following coronary angioplasty with iohexol | journal = [[Southern Medical Journal]] | volume = 100 | issue = 10 | pages = 1054–5 | year = 2007 | month = October | pmid = 17943057 | doi = 10.1097/SMJ.0b013e3181540086 | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0038-4348&volume=100&issue=10&spage=1054 | issn = | accessdate = 2011-02-05}}</ref><ref name="pmid8793235">{{cite journal | author = Muruve DA, Steinman TI | title = Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency | journal = [[Clinical Nephrology]] | volume = 45 | issue = 6 | pages = 406–9 | year = 1996 | month = June | pmid = 8793235 | doi = | url = | issn = | accessdate = 2011-02-05}}</ref>. It is associated with diffuse slowing on the [[EEG]]. The disorder is usually self limited and resolves within 24 hours. Patients with impaired creatinine clearance may be at increased risk for the disorder. Treatment is largely supportive, although one small study of 3 patients reports that [[craniectomy]] was successfully used to reduce [[cerebral edema]] <ref>A proposed treatment modality for contrast-induced encephalopathy C. Pineda, D. Brock, R. Bell, J. Provencio, L. Tartaglin. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 1 September 2003 (volume 12 issue 5 Page 249 DOI: 10.1016/j.jstrokecerebrovasdis.2003.11.012)</ref>. | ||
==References== | ==References== |
Latest revision as of 17:27, 6 February 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Retention of contrast in the brain is rare, and has been documented in only a handful of cases [1]. Contrast induced encephalopathy is also a rare disorder in which an encephalopathy occurs following iodinated contrast injections. It has been observed following angioplasty [2][1]. It is associated with diffuse slowing on the EEG. The disorder is usually self limited and resolves within 24 hours. Patients with impaired creatinine clearance may be at increased risk for the disorder. Treatment is largely supportive, although one small study of 3 patients reports that craniectomy was successfully used to reduce cerebral edema [3].
References
- ↑ 1.0 1.1 Muruve DA, Steinman TI (1996). "Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency". Clinical Nephrology. 45 (6): 406–9. PMID 8793235. Unknown parameter
|month=
ignored (help);|access-date=
requires|url=
(help) - ↑ Sawaya RA, Hammoud R, Arnaout S, Alam S (2007). "Contrast-induced encephalopathy following coronary angioplasty with iohexol". Southern Medical Journal. 100 (10): 1054–5. doi:10.1097/SMJ.0b013e3181540086. PMID 17943057. Retrieved 2011-02-05. Unknown parameter
|month=
ignored (help) - ↑ A proposed treatment modality for contrast-induced encephalopathy C. Pineda, D. Brock, R. Bell, J. Provencio, L. Tartaglin. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 1 September 2003 (volume 12 issue 5 Page 249 DOI: 10.1016/j.jstrokecerebrovasdis.2003.11.012)